Attitude of German women towards hormone therapy: results of a lay survey.

Standard

Attitude of German women towards hormone therapy: results of a lay survey. / Bühling, Kai J.; Daniels, B; von Studnitz, Friederike S G; zu Eulenburg, Christine; Mueck, A O.

In: GYNECOL ENDOCRINOL, Vol. 29, No. 5, 5, 01.05.2013, p. 460-464.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Bühling, KJ, Daniels, B, von Studnitz, FSG, zu Eulenburg, C & Mueck, AO 2013, 'Attitude of German women towards hormone therapy: results of a lay survey.', GYNECOL ENDOCRINOL, vol. 29, no. 5, 5, pp. 460-464. https://doi.org/10.3109/09513590.2012.754881

APA

Bühling, K. J., Daniels, B., von Studnitz, F. S. G., zu Eulenburg, C., & Mueck, A. O. (2013). Attitude of German women towards hormone therapy: results of a lay survey. GYNECOL ENDOCRINOL, 29(5), 460-464. [5]. https://doi.org/10.3109/09513590.2012.754881

Vancouver

Bühling KJ, Daniels B, von Studnitz FSG, zu Eulenburg C, Mueck AO. Attitude of German women towards hormone therapy: results of a lay survey. GYNECOL ENDOCRINOL. 2013 May 1;29(5):460-464. 5. https://doi.org/10.3109/09513590.2012.754881

Bibtex

@article{93b6c2648bb94035b94db8a6a4ce3ce5,
title = "Attitude of German women towards hormone therapy: results of a lay survey.",
abstract = "OBJECTIVE: Hormone therapy (HT) use has experienced a substantial change since publication of Women's Health Initiative (WHI) controlled trial. We aimed to investigate the attitude towards HT in German women aged 45-60 years.STUDY DESIGN: A questionnaire was sent to 9785 randomly selected women in Germany aged between 45 and 60 years.RESULTS: Response rate was 19.3% (n = 1,893). Of those, 81% experienced climacteric symptoms. Vasomotor symptoms were most frequently reported (71.2%; n = 1332). Of the respondents, 19.7% (n = 369) used HT. The most frequently mentioned benefits of HT were the improvement of climacteric complaints (71.2%; n = 1346), followed by the relief of osteoporosis (37.2%; n = 697) and the {"}anti-aging{"} effect (16.3%; n = 305). Breast cancer was stated as the main risk (64.9%; n = 1215), closely followed by weight gain (53.4%; n = 1000) and thromboembolism (48%; n = 898). About 44% of the women who has been advised by gynaecologists choose a HT, whereas this rate dropped down to 14.3% and 11.3% for women who have been advised by friends or media.CONCLUSION: German women were generally aware of the main risks and benefits of HT. {"}More informed{"} women appear to be more likely to use HT compared to {"}less informed{"} women. The media produces negative impression of HT.",
keywords = "Estrogen Replacement Therapy, Female, Germany, Health Knowledge, Attitudes, Practice, Hot Flashes, Humans, Information Dissemination, Middle Aged",
author = "B{\"u}hling, {Kai J.} and B Daniels and {von Studnitz}, {Friederike S G} and {zu Eulenburg}, Christine and Mueck, {A O}",
year = "2013",
month = may,
day = "1",
doi = "10.3109/09513590.2012.754881",
language = "English",
volume = "29",
pages = "460--464",
journal = "GYNECOL ENDOCRINOL",
issn = "0951-3590",
publisher = "informa healthcare",
number = "5",

}

RIS

TY - JOUR

T1 - Attitude of German women towards hormone therapy: results of a lay survey.

AU - Bühling, Kai J.

AU - Daniels, B

AU - von Studnitz, Friederike S G

AU - zu Eulenburg, Christine

AU - Mueck, A O

PY - 2013/5/1

Y1 - 2013/5/1

N2 - OBJECTIVE: Hormone therapy (HT) use has experienced a substantial change since publication of Women's Health Initiative (WHI) controlled trial. We aimed to investigate the attitude towards HT in German women aged 45-60 years.STUDY DESIGN: A questionnaire was sent to 9785 randomly selected women in Germany aged between 45 and 60 years.RESULTS: Response rate was 19.3% (n = 1,893). Of those, 81% experienced climacteric symptoms. Vasomotor symptoms were most frequently reported (71.2%; n = 1332). Of the respondents, 19.7% (n = 369) used HT. The most frequently mentioned benefits of HT were the improvement of climacteric complaints (71.2%; n = 1346), followed by the relief of osteoporosis (37.2%; n = 697) and the "anti-aging" effect (16.3%; n = 305). Breast cancer was stated as the main risk (64.9%; n = 1215), closely followed by weight gain (53.4%; n = 1000) and thromboembolism (48%; n = 898). About 44% of the women who has been advised by gynaecologists choose a HT, whereas this rate dropped down to 14.3% and 11.3% for women who have been advised by friends or media.CONCLUSION: German women were generally aware of the main risks and benefits of HT. "More informed" women appear to be more likely to use HT compared to "less informed" women. The media produces negative impression of HT.

AB - OBJECTIVE: Hormone therapy (HT) use has experienced a substantial change since publication of Women's Health Initiative (WHI) controlled trial. We aimed to investigate the attitude towards HT in German women aged 45-60 years.STUDY DESIGN: A questionnaire was sent to 9785 randomly selected women in Germany aged between 45 and 60 years.RESULTS: Response rate was 19.3% (n = 1,893). Of those, 81% experienced climacteric symptoms. Vasomotor symptoms were most frequently reported (71.2%; n = 1332). Of the respondents, 19.7% (n = 369) used HT. The most frequently mentioned benefits of HT were the improvement of climacteric complaints (71.2%; n = 1346), followed by the relief of osteoporosis (37.2%; n = 697) and the "anti-aging" effect (16.3%; n = 305). Breast cancer was stated as the main risk (64.9%; n = 1215), closely followed by weight gain (53.4%; n = 1000) and thromboembolism (48%; n = 898). About 44% of the women who has been advised by gynaecologists choose a HT, whereas this rate dropped down to 14.3% and 11.3% for women who have been advised by friends or media.CONCLUSION: German women were generally aware of the main risks and benefits of HT. "More informed" women appear to be more likely to use HT compared to "less informed" women. The media produces negative impression of HT.

KW - Estrogen Replacement Therapy

KW - Female

KW - Germany

KW - Health Knowledge, Attitudes, Practice

KW - Hot Flashes

KW - Humans

KW - Information Dissemination

KW - Middle Aged

U2 - 10.3109/09513590.2012.754881

DO - 10.3109/09513590.2012.754881

M3 - SCORING: Journal article

C2 - 23362982

VL - 29

SP - 460

EP - 464

JO - GYNECOL ENDOCRINOL

JF - GYNECOL ENDOCRINOL

SN - 0951-3590

IS - 5

M1 - 5

ER -